Drug and Alcohol Behaviors With Direct-Acting Antiviral Treatment in HCV
Researchers found data that showed patients who have or who are injecting drugs would benefit from treatment for HCV with direct-acting antivirals.
All articles by Gary Rothbard, MD, MS
Entecavir Is Comparable to Other Nucleoside Analogues for Long-Term Treatment of Chronic HBV Infection
At centers in Asia, Europe, and the Americas, investigators conducted a randomized controlled trial of patients with chronic hepatitis B virus infection to assess the long-term effects of entecavir.
Predictors of Transmission Risk in Hepatitis C
Investigators found that young age, high HCV viral load, and HCV/HIV co-infection were the factors associated with an increased transmission risk.
Entecavir for Treatment of HBV in Patients With Renal Dysfunction
Researchers found data that showed entecavir is safe in the treatment of hepatitis B virus in patients who are undergoing hemodialysis.
Early Antiviral Therapy Reduces HBsAg in Infantile Hepatitis B Infection
Researchers found data that showed early initiation of antiviral therapy with lamivudine in infants with hepatitis B caused a rapid loss of HBsAg.
